1,25-dihydroxyergocalciferol and Animal Mammary Carcinoma

1,25-dihydroxyergocalciferol has been researched along with Animal Mammary Carcinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Filip, B; Kutner, A; Milczarek, M; Nevozhay, D; Wietrzyk, J	1

Other Studies

1 other study(ies) available for 1,25-dihydroxyergocalciferol and Animal Mammary Carcinoma

Article	Year
Toxicity and antitumor activity of the vitamin D analogs PRI-1906 and PRI-1907 in combined treatment with cyclophosphamide in a mouse mammary cancer model. Cancer chemotherapy and pharmacology, 2008, Volume: 62, Issue:5 Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Calcitriol; Calcium; Cell Cycle; Cyclophosphamide; Dihydroxycholecalciferols; Ergocalciferols; Female; Lethal Dose 50; Male; Mammary Neoplasms, Animal; Mice; Mice, Inbred C3H; Mice, Inbred DBA; Vitamins	2008

Article

Year

Toxicity and antitumor activity of the vitamin D analogs PRI-1906 and PRI-1907 in combined treatment with cyclophosphamide in a mouse mammary cancer model.

Cancer chemotherapy and pharmacology, 2008, Volume: 62, Issue:5

Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Calcitriol; Calcium; Cell Cycle; Cyclophosphamide; Dihydroxycholecalciferols; Ergocalciferols; Female; Lethal Dose 50; Male; Mammary Neoplasms, Animal; Mice; Mice, Inbred C3H; Mice, Inbred DBA; Vitamins

2008